Kentaro Okunushi

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse et al. · The Lancet · 2019 · 208 citations

Medicine, Cardiology, Immunology +11

Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma

Kosuke Higuchi, Shinichi Sakamoto, Keisuke Ando et al. · Scientific Reports · 2019 · 54 citations · Full text

Medicine, Cancer Biology, Oncology +12

JPH203, a newly developed anti-cancer drug, shows a preincubation inhibitory effect on L-type amino acid transporter 1 function

Kentaro Okunushi, Tomomi Furihata, Hanae Morio et al. · Journal of Pharmacological Sciences · 2020 · 40 citations · Full text

Medicine, Oncology, Pharmacology +9

Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203

Yasuhide Muto, Tomomi Furihata, Meika Kaneko et al. · Anticancer Research · 2018 · 39 citations · Full text

Medicine, Oncology, Pharmacology +10

Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation

Tomoyuki Ohe, Ryutaro Umezawa, Yumina Kitagawara et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 13 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10